Advertisement

Biocompatibility of Bioactive Polymeric Systems

  • James M. Anderson

Abstract

It is obvious that the general area of bioactive polymeric systems is an extremely broad area of science which includes systems intended for human use, animal use, agriculture applications, and diagnostic assays. While biocompatibility considerations are important to all of these areas, the determination of biocompatibility is of utmost importance to those areas where bioactive polymeric systems are considered for human or animal use. In particular, the evaluation of biocompatibility of systems intended for implantation or injection in humans or animals is a necessary step in the research and development of such systems. It is the intent of this paper to briefly outline and describe biocompatibility procedures and methods for the evaluation of systems intended for implantation or injection into humans or animals.

Keywords

Silicone Rubber Inflammatory Exudate Bioactive Agent Rabbit Cornea Implantation Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. Black, Biological Performance of Materials: Fundamentals of Biocompatibility, Marcel Dekker, New York (1981).Google Scholar
  2. 2.
    V. H.-L. Lee and J. R. Robinson in: Sustained and Controlled Release Drug Delivery Systems (J. R. Robinson, ed.), Chapter 3, pp. 71–121, Marcel Dekker, New York (1978).Google Scholar
  3. 3.
    D. F. Williams, ed., Fundamental Aspects of Biocompatibility, Vols. I to II, CRC Press, Boca Raton, Fla. (1981).Google Scholar
  4. 4.
    D. F. Williams, ed., Biocompatibility in Clinical Practice, Vols. I & II, CRC Press, Boca Raton, Fla. (1982).Google Scholar
  5. 5.
    J. Autian, Artif Organs 1, 53 (1977).CrossRefGoogle Scholar
  6. 6.
    J. E. Turner, W. H. Lawrence, and J. Autian, J. Biomed. Mater. Res. 7, 39 (1973).CrossRefGoogle Scholar
  7. 7.
    D. L. Coleman, R. N. King, and J. D. Andrade, J. Biomed. Mater. Res. 8, 199 (1974).CrossRefGoogle Scholar
  8. 8.
    D. L. Coleman, R. N. King, and J. D. Andrade, J. Biomed. Mater. Res. Symp. 5(1), 65 (1974).CrossRefGoogle Scholar
  9. 9.
    R. H. Rigdon, CRC Crit. Rev. Food Sci. Nutrit. 7, 435 (1975).Google Scholar
  10. 10.
    L. Marion, E. Haugen, and I. A. Mjor, J. Biomed. Mater. Res. 14, 343 (1980).CrossRefGoogle Scholar
  11. 11.
    R. I. Leininger, CRC Crit. Rev. Bioeng. 1, 333 (1972).Google Scholar
  12. 12.
    C. A. Homsy, J. Biomed. Mater. Res. 4, 341 (1970).CrossRefGoogle Scholar
  13. 13.
    S. J. Gourlay, R. M. Rice, A. F. Hegyeli, C. W. R. Wade, J. G. Dillon, H. Jaffe, and R. K. Kulkarni, J. Biomed. Mater. Res. 12, 219 (1978).CrossRefGoogle Scholar
  14. 14.
    R. Langer, H. Brem, and D. Tapper, J. Biomed. Mater. Res. 15, 267 (1981).CrossRefGoogle Scholar
  15. 15.
    S. B. Aaronson and R. C. Horton, Arch. Ophthalmol. 85, 306 (1971).CrossRefGoogle Scholar
  16. 16.
    J. E. Gray in: Sustained and Controlled Release Drug Delivery Systems (J. R. Robinson, ed.), Chapter 5, pp. 351–410, Marcel Dekker, New York (1978).Google Scholar
  17. 17.
    R. Gurny, N. A. Peppas, D. D. Harrington, and G. S. Banker, Drug Dev. Ind. Pharm. 7, 1 (1981).CrossRefGoogle Scholar
  18. 18.
    L. G. Donaruma, R. M. Ottenbrite, and O. Vogl, eds., Anionic Polymeric Drugs, Wiley, New York (1981).Google Scholar
  19. 19.
    G. Gregoriadis, Drug Carriers in Biology and Medicine, Academic Press, London (1979).Google Scholar
  20. 20.
    H. Ringsdorf, J. Polym. Sci., Polym. Symp. 51, 135 (1975).CrossRefGoogle Scholar
  21. 21.
    E. Chiellini and P. Guisti, eds., Polymers in Medicine: Biomedical and Pharmacological Applications, Plenum Press, New York (1983) (in press).Google Scholar
  22. 22.
    T. N. Salthouse and B. F. Matlaga in: Fundamental Aspects of Biocompatibility (D. F. Williams, ed.), Volume II, pp. 233–257, CRC Press, Boca Raton, Fla. (1981).Google Scholar
  23. 23.
    T. N. Salthouse and B. F. Matlaga, Ann. Histochim. 21, 105 (1976).Google Scholar
  24. 24.
    T. N. Salthouse, B. F. Matlaga, and R. K. O’Leary, Toxicol. Appl. Pharmacol. 25, 201 (1973).CrossRefGoogle Scholar
  25. 25.
    R. Marchant, A. Hiltner, C. Hamlin, A. Rabinovitch, R. Slobodkin, and J. M. Anderson, J. Biomed. Mater. Res. 17, 301 (1983).CrossRefGoogle Scholar
  26. 26.
    J. M. Anderson, R. Marchant, and M. McClurken, in: Long-Acting Contraceptive Delivery Systems (G. I. Zatuchni et al., eds.), p. 248, Harper & Row, New York (1984).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • James M. Anderson
    • 1
  1. 1.Departments of Pathology and Macromolecular ScienceCase Western Reserve UniversityClevelandUSA

Personalised recommendations